Market Cap 393.08M
Revenue (ttm) 70.01M
Net Income (ttm) 9.95M
EPS (ttm) N/A
PE Ratio 16.61
Forward PE 16.61
Profit Margin 14.21%
Debt to Equity Ratio 0.00
Volume 158,514
Avg Vol 459,840
Day's Range N/A - N/A
Shares Out 20.13M
Stochastic %K 96%
Beta 1.16
Analysts Strong Sell
Price Target $23.00

Company Profile

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides prod...

Industry: Health Information Services
Sector: Healthcare
Phone: 661 723 7723
Address:
800 Park Offices Drive, Suite 401, Research Triangle Park, United States
Iightning
Iightning Dec. 4 at 7:45 AM
1ightning® Premium Options Alert (Actionable) Ticker: $SLP Contract: Dec 19 $20C Entry: 1.52 Exit: 2.72 Return: +78.19% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 3 at 10:44 AM
1ightning® Premium Options Alert (Actionable) Ticker: $SLP Contract: Dec 19 $5C Entry: 12.55 Exit: 17.31 Return: +37.90% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Godwins26
Godwins26 Dec. 2 at 9:34 PM
2nd Watchlist for today 😊 $PLRZ it's going to $10 $SMX $THH $TMC $SLP
1 · Reply
topstockalerts
topstockalerts Dec. 2 at 5:00 PM
$SLP Looking good!
0 · Reply
d_risk
d_risk Dec. 2 at 3:50 PM
$SLP - Simulations Plus Inc. Common Stock - 10K - Updated Risk Factors SLP’s 2025 10-K risk factors clarify “clients” over “customers,” sharpen focus on model-informed drug development, highlight AI/ML as both a competitive and legal risk, expand on pricing and demand pressures, detail new government grant and shutdown risks, and note recent share repurchase volatility—no major shifts, but more specificity and new AI, grant, and shutdown disclosures. #ModelInformedDrugDevelopment #ShareRepurchaseVolatility #GovernmentGrants #PricingPressure #AIMLRisks 🟢 Added 🟠 Removed https://d-risk.ai/SLP/10-K/2025-12-01
0 · Reply
ZacksResearch
ZacksResearch Dec. 2 at 2:07 PM
Soft quarter, but is $SLP setting up its next growth phase anyway? SLP’s fiscal Q4 2025 earnings and sales fell year over year, but the company still met full-year goals as cloud, AI, and integrated workflows shape what comes next. Get the full performance breakdown here 👉 https://www.zacks.com/stock/news/2798187/simulations-plus-q4-earnings-sales-meet-estimates-fall-yy?cid=sm-stocktwits-2-2798187-teaser-22981&ADID=SYND_STOCKTWITS_TWEET_2_2798187_TEASER_22981
0 · Reply
ZacksResearch
ZacksResearch Dec. 2 at 1:07 PM
$SLP Q4: A Resilient Pivot Amidst Challenges! 🚀 Despite a 6% revenue dip to $17.5M due to market shifts, $SLP met its fiscal 2025 guidance and grew FY revenues by 13% to $79.2M. Cloud, AI, and integrated workflows are set to drive future growth. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2798187/simulations-plus-q4-earnings-sales-meet-estimates-fall-yy?cid=sm-stocktwits-2-2798187-body-22979&ADID=SYND_STOCKTWITS_TWEET_2_2798187_BODY_22979
0 · Reply
Iightning
Iightning Dec. 2 at 2:12 AM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $SLP **Contract:** Dec 19 $17.5C **Entry:** 1.17 **Exit:** 1.84 **Return:** **+57.56% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
eWhispers
eWhispers Dec. 1 at 6:22 PM
#earnings after the close on Monday, December 1, 2025, and before the open on Tuesday, December 2, 2025 https://www.earningswhispers.com/calendar $CRDO $BNS $MDB $SIG $SLP
0 · Reply
Iightning
Iightning Nov. 26 at 5:07 AM
1ightning® Options Trade Alert (Actionable) | Buy $SLP Dec 19 $18 Call | Enter: $1.04 Exit: $1.85 | Profit: 77.61% ROI | https://1ightning.com
0 · Reply
Latest News on SLP
Why Shares of Simulations Plus Soared This Week

Dec 4, 2025, 12:30 PM EST - 1 hour ago

Why Shares of Simulations Plus Soared This Week


Why Simulations Plus Stock Was Soaring Today

Dec 2, 2025, 3:40 PM EST - 1 day ago

Why Simulations Plus Stock Was Soaring Today


Simulations Plus to Participate in Upcoming Investor Conferences

Aug 27, 2025, 7:50 AM EDT - 3 months ago

Simulations Plus to Participate in Upcoming Investor Conferences


Simulations Plus Sees Weaker Demand Persist, Outlook Softens

Jul 15, 2025, 1:56 PM EDT - 5 months ago

Simulations Plus Sees Weaker Demand Persist, Outlook Softens


Simulations Plus (SLP) Q3 2025 Earnings Transcript

Jul 15, 2025, 8:43 AM EDT - 5 months ago

Simulations Plus (SLP) Q3 2025 Earnings Transcript


Iightning
Iightning Dec. 4 at 7:45 AM
1ightning® Premium Options Alert (Actionable) Ticker: $SLP Contract: Dec 19 $20C Entry: 1.52 Exit: 2.72 Return: +78.19% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 3 at 10:44 AM
1ightning® Premium Options Alert (Actionable) Ticker: $SLP Contract: Dec 19 $5C Entry: 12.55 Exit: 17.31 Return: +37.90% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Godwins26
Godwins26 Dec. 2 at 9:34 PM
2nd Watchlist for today 😊 $PLRZ it's going to $10 $SMX $THH $TMC $SLP
1 · Reply
topstockalerts
topstockalerts Dec. 2 at 5:00 PM
$SLP Looking good!
0 · Reply
d_risk
d_risk Dec. 2 at 3:50 PM
$SLP - Simulations Plus Inc. Common Stock - 10K - Updated Risk Factors SLP’s 2025 10-K risk factors clarify “clients” over “customers,” sharpen focus on model-informed drug development, highlight AI/ML as both a competitive and legal risk, expand on pricing and demand pressures, detail new government grant and shutdown risks, and note recent share repurchase volatility—no major shifts, but more specificity and new AI, grant, and shutdown disclosures. #ModelInformedDrugDevelopment #ShareRepurchaseVolatility #GovernmentGrants #PricingPressure #AIMLRisks 🟢 Added 🟠 Removed https://d-risk.ai/SLP/10-K/2025-12-01
0 · Reply
ZacksResearch
ZacksResearch Dec. 2 at 2:07 PM
Soft quarter, but is $SLP setting up its next growth phase anyway? SLP’s fiscal Q4 2025 earnings and sales fell year over year, but the company still met full-year goals as cloud, AI, and integrated workflows shape what comes next. Get the full performance breakdown here 👉 https://www.zacks.com/stock/news/2798187/simulations-plus-q4-earnings-sales-meet-estimates-fall-yy?cid=sm-stocktwits-2-2798187-teaser-22981&ADID=SYND_STOCKTWITS_TWEET_2_2798187_TEASER_22981
0 · Reply
ZacksResearch
ZacksResearch Dec. 2 at 1:07 PM
$SLP Q4: A Resilient Pivot Amidst Challenges! 🚀 Despite a 6% revenue dip to $17.5M due to market shifts, $SLP met its fiscal 2025 guidance and grew FY revenues by 13% to $79.2M. Cloud, AI, and integrated workflows are set to drive future growth. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2798187/simulations-plus-q4-earnings-sales-meet-estimates-fall-yy?cid=sm-stocktwits-2-2798187-body-22979&ADID=SYND_STOCKTWITS_TWEET_2_2798187_BODY_22979
0 · Reply
Iightning
Iightning Dec. 2 at 2:12 AM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $SLP **Contract:** Dec 19 $17.5C **Entry:** 1.17 **Exit:** 1.84 **Return:** **+57.56% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
eWhispers
eWhispers Dec. 1 at 6:22 PM
#earnings after the close on Monday, December 1, 2025, and before the open on Tuesday, December 2, 2025 https://www.earningswhispers.com/calendar $CRDO $BNS $MDB $SIG $SLP
0 · Reply
Iightning
Iightning Nov. 26 at 5:07 AM
1ightning® Options Trade Alert (Actionable) | Buy $SLP Dec 19 $18 Call | Enter: $1.04 Exit: $1.85 | Profit: 77.61% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 3:15 PM
1ightning® Options Trade Alert (Actionable) | Buy $SLP Dec 19 $18 Call | Enter: $1.04 Exit: $1.85 | Profit: 77.61% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 4:10 AM
1ightning® Options Trade Alert (Actionable) | Buy $SLP Dec 19 $18 Call | Enter: $1.04 Exit: $1.85 | Profit: 77.61% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 22 at 1:21 AM
1ightning® Options Trade Alert (Actionable) | Buy $SLP Dec 19 $18 Call | Enter: $1.14 Exit: $2.04 | Profit: 79.04% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 21 at 4:43 AM
1ightning® Options Trade Alert (Actionable) | Buy $SLP Dec 19 $18 Call | Enter: $1.14 Exit: $2.04 | Profit: 79.04% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 20 at 2:23 AM
1ightning® Options Trade Alert (Actionable) | Buy $SLP Dec 19 $18 Call | Enter: $1.14 Exit: $2.04 | Profit: 79.04% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 10:18 AM
1ightning® Options Trade Alert (Actionable) | Buy $SLP Dec 19 $18 Call | Enter: $1.14 Exit: $2.04 | Profit: 79.04% ROI | https://1ightning.com
0 · Reply
RunnerSignals
RunnerSignals Nov. 15 at 7:46 AM
Big Upside Stocks to Watch $GEV $MBX $XPEV $APLD $SLP are flashing massive potential! Full pro subscriber analysis reveals who could break out first https://stocksrunner.com/news/2025-11-14-short-term-stocks-with-analyst-upgrades-and-upside
0 · Reply
DocPharm
DocPharm Oct. 29 at 2:09 PM
$SLP going to start a position here; waiting for entry
0 · Reply
lucianw
lucianw Oct. 22 at 8:27 PM
$SLP nice. Finally some movement we deserve. This actually made me more confident about the upcoming ER for some of my other medtech holdings.
0 · Reply
topstockalerts
topstockalerts Oct. 22 at 2:36 PM
$SLP there it goes…
0 · Reply
DaBullRunner
DaBullRunner Oct. 22 at 2:15 PM
$SLP there it goes… SCNX watching closely as this company is the only one I know trading under $1 with TWO FDA approved products 🚨🚨🚨
1 · Reply